A case series of mucormycosis, post COVID-19 in a tertiary care centre
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20230411Keywords:
Mucormycosis, Hyperglycemia, Steroid intakeAbstract
In the 3rd wave of COVID-19 especially in India, an associated angio-invasive opportunistic infection with mucormycosis is emerged. The clinical, imaging and treatment data of 22 patients with mucormycosis was analyzed. Clinical features observed are periorbital swelling, facial pain, swelling of cheek, nasal discharge, dental pain associated with loose tooth. Imaging demonstrated PNS, orbital and intracranial extension in 100%, 55%, 20% patients respectively. All received ampho-B and underwent endoscopic debridement, 20% orbital decompression and 5% maxillectomy, 2 patients died. The association of hyperglycemia and steroid intake warrants judicious use of corticosteroids and optimal glycemic control. Good clinical outcome is achieved by aggressive surgical debridement and antifungal medication with optimal glycemic control.
Metrics
References
Patil A, Mohanty HS, Kumar S, Nandikoor S, Meganathan P. Angioinvasive rhinocerebral mucormycosis with complete unilateral thrombosis of internal carotid artery-case report and review of literature. BJR Case Rep. 2016;2(2):20150448.
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146.
Kaneria MV, Baligeri K, Budhe A. Post COVID-19 mucormycosis: A case series. Asian Pac J Trop Med. 2021;14:517-24.
Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis. 2021;27(9):2349-59.
Badiee P, Arastefar A, Jafarian H. Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens. Iran J Microbiol. 2013;5(4):406-10.
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146.
Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis-The bitter and the sweet. PLoS Pathog. 2017;13(8):e1006408.
Bhandari J, Thada PK, Nagalli S. Rhinocerebral Mucormycosis. Treasure Island, FL: StatPearls Publishing; 2021.
Kumar G, Adams A, Hererra M, Rojas ER, Singh V, Sakhuja A, et al. Predictors and outcomes of hais in COVID-19 patients. Int J Infect Dis. 2020;104(3):287-92.
Anaissie EJ, Mattiuzzi GN, Miller CB, Noskin GA, Gurwith MJ, Mamelok RD, et al. Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion. Antimicrob Agents Chemother. 1998;42(3):606-11.
